Evidence map›Paper›PMID 32244667›Full record

ArticleNutrients2020

Diminished Vitamin D Receptor Protein Levels in Crohn's Disease Fibroblasts: Effects of Vitamin D.

Laura Gisbert-Ferrándiz, Jesús Cosín-Roger, Carlos Hernández, Dulce C Macias-Ceja, Dolores Ortiz-Masiá, Pedro Salvador, Juan V Esplugues, Joaquín Hinojosa, Francisco Navarro, Sara Calatayud and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Nutrients · 2024
    Article
  5. Article
  6. Prospective therapeutics for intestinal and hepatic fibrosis.Bioengineering & translational medicine · 2023
    Review
  7. Article
  8. [Mechanism of action and exogenous supplementation of vitamin D in Crohn's disease].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Laura Gisbert-FerrándizDepartamento de Farmacología and CIBER, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain.ORCID 0000-0002-2007-8716
Jesús Cosín-RogerFundación para la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO, 46015 Valencia, Spain.
Carlos HernándezFundación para la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO, 46015 Valencia, Spain.ORCID 0000-0001-8536-429X
Dulce C Macias-CejaFundación para la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, FISABIO, 46015 Valencia, Spain.
Dolores Ortiz-MasiáDepartamento de Medicina, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain.
Pedro SalvadorDepartamento de Farmacología and CIBER, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain.
Juan V EspluguesDepartamento de Farmacología and CIBER, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain.ORCID 0000-0001-8205-021X
Joaquín HinojosaHospital de Manises, 46940 Valencia, Spain.
Francisco NavarroHospital de Manises, 46940 Valencia, Spain.ORCID 0000-0002-9775-3169
Sara CalatayudDepartamento de Farmacología and CIBER, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain.ORCID 0000-0001-9675-2423
María D BarrachinaDepartamento de Farmacología and CIBER, Facultad de Medicina, Universidad de Valencia, 46010 Valencia, Spain.
Universitat de València · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHospital de Manises · ES

Funding

Generalitat Valenciana [PROMETEOIII/2018/141]Ministerio de Economía, Industria y Competitividad, Gobierno de España (SAF2016-80072P)
6 · The paper itself

Abstract

Vitamin D (VD) deficiency has been associated to Crohn's disease (CD) pathogenesis, and the exogenous administration of VD improves the course of the disease, but the mechanistic basis of these observations remains unknown. Vitamin D receptor (VDR) mediates most of the biological functions of this hormone, and we aim to analyze here the expression of VDR in intestinal tissue, epithelial cells, and fibroblasts from CD patients. The effects of VD on a fibroblast wound healing assay and murine intestinal fibrosis are also analyzed. Our data show diminished VDR protein levels in surgical resections and epithelial cells from CD patients. In intestinal fibroblasts isolated from damaged tissue of CD patients, we detected enhanced migration and decreased VDR expression compared with both fibroblasts from non-damaged tissue of the same CD patient or control fibroblasts. Treatment with VD increased VDR protein levels, avoided the accelerated migration in CD fibroblasts, and prevented murine intestinal fibrosis induced by the heterotopic transplant model. In conclusion, our study demonstrates diminished VDR protein levels associated with enhanced migration in intestinal fibroblasts from damaged tissue of CD patients. In these cells, VD accumulates VDR and normalizes migration, which supports that CD patients would benefit from the VD anti-fibrotic therapeutic value that we demonstrate in a murine experimental model.

Indexed as

AnimalsCell MovementCrohn DiseaseDisease Models, AnimalEpithelial CellsFemaleFibroblastsFibrosisGene Expression RegulationHumansIntestinesMaleMice, Inbred C57BLReceptors, CalcitriolVitamin DVitamin D DeficiencyReceptors, CalcitriolVitamin DCrohn’s diseasefibroblastsfibrosisvitamin Dvitamin D receptor (VDR)

Identifiers

PMID32244667
PMCPMC7230839
OpenAlexW3015102222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.